Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

882 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cystic fibrosis, lung infections, and a human tracheal antimicrobial peptide (hTAP).
Ko YH, Delannoy M, Pedersen PL. Ko YH, et al. FEBS Lett. 1997 Mar 24;405(2):200-8. doi: 10.1016/s0014-5793(97)00189-0. FEBS Lett. 1997. PMID: 9089291
Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.
Annereau JP, Ko YH, Pedersen PL. Annereau JP, et al. Among authors: ko yh. Biochem J. 2003 Apr 15;371(Pt 2):451-62. doi: 10.1042/BJ20021318. Biochem J. 2003. PMID: 12523935 Free PMC article.
Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.
Ko YH, Pedersen PL. Ko YH, et al. J Bioenerg Biomembr. 2001 Dec;33(6):513-21. doi: 10.1023/a:1012831322753. J Bioenerg Biomembr. 2001. PMID: 11804193 Review.
Cystic fibrosis transmembrane conductance regulator: solution structures of peptides based on the Phe508 region, the most common site of disease-causing DeltaF508 mutation.
Massiah MA, Ko YH, Pedersen PL, Mildvan AS. Massiah MA, et al. Among authors: ko yh. Biochemistry. 1999 Jun 8;38(23):7453-61. doi: 10.1021/bi9903603. Biochemistry. 1999. PMID: 10360942
Overexpression, purification, and function of first nucleotide-binding fold of cystic fibrosis transmembrane conductance regulator.
Ko YH, Pedersen PL. Ko YH, et al. Methods Enzymol. 1998;292:675-86. doi: 10.1016/s0076-6879(98)92052-3. Methods Enzymol. 1998. PMID: 9711591 No abstract available.
Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR).
Bianchet MA, Ko YH, Amzel LM, Pedersen PL. Bianchet MA, et al. Among authors: ko yh. J Bioenerg Biomembr. 1997 Oct;29(5):503-24. doi: 10.1023/a:1022443209010. J Bioenerg Biomembr. 1997. PMID: 9511935
This prediction has been verified experimentally [Ko, Y.H., and Pedersen, P.L. (1995) J. Biol. Chem. 268, 24330-24338], providing support for the model. ...
This prediction has been verified experimentally [Ko, Y.H., and Pedersen, P.L. (1995) J. Biol. Chem. 268, 24330-24338], providing sup …
Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease.
Ko YH, Pedersen PL. Ko YH, et al. J Bioenerg Biomembr. 1997 Oct;29(5):417-27. doi: 10.1023/a:1022402105375. J Bioenerg Biomembr. 1997. PMID: 9511927 Review.
Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function.
Ko YH, Delannoy M, Pedersen PL. Ko YH, et al. Biochemistry. 1997 Apr 22;36(16):5053-64. doi: 10.1021/bi9630265. Biochemistry. 1997. PMID: 9125527
Nucleotide domains in transport ATPases: structure-function and relationship to disease.
Thomas PJ, Ko YH, Shenbagamurthi P, Pedersen PL. Thomas PJ, et al. Among authors: ko yh. Soc Gen Physiol Ser. 1995;50:17-28. Soc Gen Physiol Ser. 1995. PMID: 7676321 Review. No abstract available.
882 results
Jump to page
Feedback